PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 21999734-0 2011 Interaction of human brain acetylcholinesterase with cyclophosphamide: a molecular modeling and docking study. Cyclophosphamide 53-69 acetylcholinesterase (Cartwright blood group) Homo sapiens 27-47 22483282-1 2012 This study describes molecular interactions between human brain acetylcholinesterase (AChE) and the well known anti-neoplastic drug, methotrexate (MTX) and its comparison to "AChE-cyclophosphamide (CP) interactions" that we reported previously. Cyclophosphamide 180-196 acetylcholinesterase (Cartwright blood group) Homo sapiens 175-179 22229321-0 2011 Human platelet acetylcholinesterase inhibition by cyclophosphamide: a combined experimental and computational approach. Cyclophosphamide 50-66 acetylcholinesterase (Cartwright blood group) Homo sapiens 15-35 22229321-2 2011 In the present study, a comparative multiple 4 dimensional (4D)-approach was applied to analyze human platelet AChE-inhibition by cyclophosphamide (CP). Cyclophosphamide 130-146 acetylcholinesterase (Cartwright blood group) Homo sapiens 111-115 21999734-1 2011 This study describes the interaction between human acetylcholinesterase (AChE), a key regulator of central and peripheral cholinergic function, and the widely used nitrogen mustard alkylating agent, cyclophosphamide (CP). Cyclophosphamide 199-215 acetylcholinesterase (Cartwright blood group) Homo sapiens 51-71 21999734-1 2011 This study describes the interaction between human acetylcholinesterase (AChE), a key regulator of central and peripheral cholinergic function, and the widely used nitrogen mustard alkylating agent, cyclophosphamide (CP). Cyclophosphamide 199-215 acetylcholinesterase (Cartwright blood group) Homo sapiens 73-77 9611965-11 1998 DISCUSSION: The activity of enzyme acetylcholinesterase depends on functional state of the liver, as well as the therapy with some drugs (cyclophosphamide, ecothiopate etc.). Cyclophosphamide 138-154 acetylcholinesterase (Cartwright blood group) Homo sapiens 35-55 8799456-1 1996 The present work addresses the effects of three antineoplastic drugs [cyclophosphamide (CP), cisplatin (CDDP) and methotrexate (MTX) which are in current use for the treatment of various tumors] on turnover kinetics of human erythrocyte membrane-bound acetylcholinesterase (AcChoEase, EC 3.1.1.7). Cyclophosphamide 70-86 acetylcholinesterase (Cartwright blood group) Homo sapiens 252-272 8799456-1 1996 The present work addresses the effects of three antineoplastic drugs [cyclophosphamide (CP), cisplatin (CDDP) and methotrexate (MTX) which are in current use for the treatment of various tumors] on turnover kinetics of human erythrocyte membrane-bound acetylcholinesterase (AcChoEase, EC 3.1.1.7). Cyclophosphamide 70-86 acetylcholinesterase (Cartwright blood group) Homo sapiens 274-283 7863507-0 1995 Inhibition of human acetylcholinesterase by cyclophosphamide. Cyclophosphamide 44-60 acetylcholinesterase (Cartwright blood group) Homo sapiens 20-40 7863507-1 1995 The inhibitory effect of cyclophosphamide (CP) on human erythrocyte membrane bound acetylcholinesterase (AChE) was investigated in the present study. Cyclophosphamide 25-41 acetylcholinesterase (Cartwright blood group) Homo sapiens 83-103 7863507-1 1995 The inhibitory effect of cyclophosphamide (CP) on human erythrocyte membrane bound acetylcholinesterase (AChE) was investigated in the present study. Cyclophosphamide 25-41 acetylcholinesterase (Cartwright blood group) Homo sapiens 105-109